ArticleAnnals of hematology2024

FLT3 inhibitors and hematopoietic cell transplantation prolong survival in patients with FLT3-ITD-positive AML.

Toshihiro Matsukawa et al.PubMed ↗Publisher ↗

No numbers read from the abstract.